The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
Open accessAbstract
Purpose: Diffuse intrinsic pontine glioma (DIPG) is a brainstem malignancy with a median survival of < 1 year. The International and European Society for Pediatric Oncology DIPG Registries collaborated to compare clinical, radiologic, and histomolecular characteristics between short-term survivors (STSs) and long-term survivors (LTSs). Materials and Methods: Data abstracted from registry databases included patients from North America, Australia, Germany, Austria, Switzerland, the Netherlands, Italy, France, the United Kingdom, and Croatia. Results: Among 1,130 pediatric and young adults with radiographically confirmed DIPG, 122 (11%) were excluded. Of the 1,008 remaining patients, 101 (10%) were LTSs (survival ≥ 2 years). Median survival time was 11 months (interquartile range, 7.5 to 16 months), and 1-, 2-, 3-, 4-, and 5-year survival rates were 42.3% (95% CI, 38.1% to 44.1%), 9.6% (95% CI, 7.8% to 11.3%), 4.3% (95% CI, 3.2% to 5.8%), 3.2% (95% CI, 2.4% to 4.6%), and 2.2% (95% CI, 1.4% to 3.4%), respectively. LTSs, compared with STSs, more commonly presented at age < 3 or > 10 years (11% v 3% and 33% v 23%, respectively; P < .001) and with longer symptom duration ( P < .001). STSs, compared with LTSs, more commonly presented with cranial nerve palsy (83% v 73%, respectively; P = .008), ring enhancement (38% v 23%, respectively; P = .007), necrosis (42% v 26%, respectively; P = .009), and extrapontine extension (92% v 86%, respectively; P = .04). LTSs more commonly received systemic therapy at diagnosis (88% v 75% for STSs; P = .005). Biopsies and autopsies were performed in 299 patients (30%) and 77 patients (10%), respectively; 181 tumors (48%) were molecularly characterized. LTSs were more likely to harbor a HIST1H3B mutation (odds ratio, 1.28; 95% CI, 1.1 to 1.5; P = .002). Conclusion: We report clinical, radiologic, and molecular factors that correlate with survival in children and young adults with DIPG, which are important for risk stratification in future clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,442
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Khuong-Quang, D.-A., Buczkowicz, P., Rakopoulos, P., Liu, X.-Y., Fontebasso, A. M., Bouffet, E., Bartels, U., Albrecht, S., Schwartzentruber, J., Letourneau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0998-0 · Cited by 1,028 · cited 2×
“43 African 4 (9) 43 (12) Asian 2 (4) 14 (4) White 36 (80) 237 (69) Other 3 (7) 50 (15) Median age, years (range) 7.”
Self-citationCastel, D., Philippe, C., Calmon, R., Le Dret, L., Truffaux, N., Boddaert, N., Pagès, M., Taylor, K. R., Saulnier, P., Lacroix, L., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1478-0 · Cited by 664
Self-citationDiffuse brainstem glioma in children: critical review of clinical trials
Hargrave, D., Bartels, U., & Bouffet, E. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70615-5 · Cited by 634
Self-citationDiffuse intrinsic pontine gliomas: A systematic update on clinical trials and biology
Jansen, M. H. A., van Vuurden, D. G., Vandertop, W. P., & Kaspers, G. J. L. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.06.007 · Cited by 232
Self-citationJansen, M. H., Veldhuijzen van Zanten, S. E., Sanchez Aliaga, E., Heymans, M. W., Warmuth-Metz, M., Hargrave, D., van der Hoeven, E. J., Gidding, C. E., de Bont, E. S., Eshghi, O. S., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou104 · Cited by 200
Self-citationGururangan, S., Fangusaro, J., Poussaint, T. Y., McLendon, R. E., Onar-Thomas, A., Wu, S., Packer, R. J., Banerjee, A., Gilbertson, R. J., Fahey, F., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not154 · Cited by 163
Self-citationJanssens, G. O. R. J., Gandola, L., Bolle, S., Mandeville, H., Albiac, M. R., Beek, K. V., Benghiat, H., Hoeben, B. A. W., Madrid, A. M. L., Kortmann, R., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.007 · Cited by 162
Self-citationGeoerger, B., Hargrave, D., Thomas, F., Ndiaye, A., Frappaz, D., Andreiuolo, F., Varlet, P., Aerts, I., Riccardi, R., Jaspan, T., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq141 · Cited by 159
Self-citationPollack, I. F., Stewart, C. F., Koçak, M., Poussaint, T. Y., Broniscer, A., Banerjee, A., Douglas, J. G., Kun, L. E., Boyett, J. M., & Geyer, J. R. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq199 · Cited by 131
Self-citationBroniscer, A., Baker, J. N., Tagen, M., Onar‐Thomas, A., Gilbertson, R. J., Davidoff, A. M., Panandiker, A. S. P., Leung, W. H., Chin, T. K., Stewart, C. F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.3545 · Cited by 126
Self-citationBailey, S., Howman, A. J., Wheatley, K., Wherton, D., Boota, N., Pizer, B. L., Fisher, D., Kearns, P. R., Picton, S. V., Saran, F. H., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.006 · Cited by 112
Self-citationConventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma
Hargrave, D. R., Chuang, N. A., & Bouffet, É. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9473-5 · Cited by 108
Self-citationon behalf of the members of the SIOPE DIPG Network, van Zanten, S. E. M. V., Baugh, J., Chaney, B., de Jongh, D., Aliaga, E. S., Barkhof, F., Noltes, J., Wolf, R. D., Dijk, J. V., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2363-y · Cited by 71
Self-citationClinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma
Jackson, S., Patay, Z. J., Howarth, R., Panandiker, A. S. P., Onar‐Thomas, A., Gajjar, A. J., & Broniscer, A. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1189-0 · Cited by 70
Self-citationBartels, U. K., Wolff, J. E. A., Gore, L., Dunkel, I. J., Gilheeney, S. W., Allen, J. C., Goldman, S., Yalon, M., Packer, R. J., Korones, D. N., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou091 · Cited by 62
Self-citationHassan, H., Pinches, A., Picton, S. V., & Phillips, R. S. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2546-1 · Cited by 56
van Zanten, S. E. M. V., Jansen, M. H. A., Aliaga, E. S., van Vuurden, D. G., Vandertop, W. P., & Kaspers, G. J. L. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2015.974563 · Cited by 54
Self-citationHummel, T. R., Salloum, R., Drissi, R., Kumar, S. S., Sobo, M., Goldman, S., Pai, A. L. H., Leach, J., Lane, A., Pruitt, D. W., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-2008-6 · Cited by 52
Self-citationBaugh, J., Bartels, U. K., Leach, J. L., Jones, B. V., Chaney, B., Warren, K. E., Kirkendall, J., Doughman, R., Hawkins, C. E., Miles, L., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2372-5 · Cited by 44
Self-citationSecond re-irradiation for DIPG progression, re-considering “old strategies” with new approaches
Madrid, A. M. L., Santa‐María, V., Martinez, O. C., Mora, J., Puerta, P., Quesada, A. G., Capella, M. S., Gomez‐Pallete, C. D. T., Lassaletta, Á., Laperrière, N., et al. (2017) · Child s Nervous System · doi:10.1007/s00381-017-3352-y · Cited by 28
Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas
Gokce-Samar, Z., Beuriat, P.-A., Faure‐Conter, C., Carrié, C., Chabaud, S., Claude, L., Rocco, F. D., Mottolèse, C., Szathmári, A., Chabert, C., et al. (2016) · Child s Nervous System · doi:10.1007/s00381-016-3153-8 · Cited by 23
Cited by
Automatic Segmentation of Rare Pediatric Brain Tumors Using Knowledge Transfer From Adult Data
Liu, X., Bonner, E. R., Jiang, Z., Roth, H. R., Muhammad Anwar, S., Packer, R. J., Bornhorst, M., & Linguraru, M. G. (2023) · 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi53787.2023.10230757 · Cited by 24
“The condition has very poor clinical outcome with a median overall survival (OS) of 11 months from diagnosis [2].”
BackgroundSelf-citation
Metadata
- Authors
- Hoffman, L. M., Veldhuijzen van Zanten, S. E. M., Colditz, N., Baugh, J., Chaney, B., Hoffmann, M., Lane, A., Fuller, C., Miles, L., Hawkins, C., Bartels, U., Bouffet, E., Goldman, S., Leary, S., Foreman, N. K., Packer, R., Warren, K. E., Broniscer, A., Kieran, M. W., Minturn, J., Comito, M., Broxson, E., Shih, C.-S., Khatua, S., Chintagumpala, M., Carret, A. S., Escorza, N. Y., Hassall, T., Ziegler, D. S., Gottardo, N., Dholaria, H., Doughman, R., Benesch, M., Drissi, R., Nazarian, J., Jabado, N., Boddaert, N., Varlet, P., Giraud, G., Castel, D., Puget, S., Jones, C., Hulleman, E., Modena, P., Giagnacovo, M., Antonelli, M., Pietsch, T., Gielen, G. H., Jones, D. T. W., Sturm, D., Pfister, S. M., Gerber, N. U., Grotzer, M. A., Pfaff, E., von Bueren, A. O., Hargrave, D., Solanki, G. A., Jadrijevic Cvrlje, F., Kaspers, G. J. L., Vandertop, W. P., Grill, J., Bailey, S., Biassoni, V., Massimino, M., Calmon, R., Sanchez, E., Bison, B., Warmuth-Metz, M., Leach, J., Jones, B., van Vuurden, D. G., Kramm, C. M., & Fouladi, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2018-07-01
- Volume
- 36
- Issue
- 19
- Pages
- 1963-1972
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2802016878
- Cited by
- 425
- References
- 24
- FWCI
- 17.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.